Italia markets close in 1 hour 5 minutes

Takeda Pharmaceutical Company Limited (4502.T)

Tokyo - Tokyo Prezzo differito. Valuta in JPY.
Aggiungi a watchlist
4.195,00-72,00 (-1,69%)
Alla chiusura: 03:15PM JST
Schermo intero
Chiusura precedente4.267,00
Aperto4.279,00
Denaro4.192,00 x 0
Domanda4.196,00 x 0
Min-Max giorno4.170,00 - 4.284,00
Intervallo di 52 settimane3.852,00 - 4.873,00
Volume3.495.300
Media Volume4.100.379
Capitalizzazione6,649T
Beta (mensile su 5 anni)0,50
Rapporto PE (ttm)44,69
EPS (ttm)93,87
Prossima data utili31 ott 2024
Rendimento e dividendo (futuro)196,00 (4,59%)
Data ex dividendo27 set 2024
Stima target 1A4.751,90
  • GlobeNewswire

    HUTCHMED Announces Submission of New Drug Application for Fruquintinib for Previously Treated Metastatic Colorectal Cancer in Japan

    — Third major market authorization application based on data from the FRESCO-2 global Phase III trial —HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Sept. 29, 2023 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (Nasdaq/AIM:​HCM, HKEX:​13) (“HUTCHMED”) today announced that Takeda (TSE:4502/​NYSE:TAK) has submitted a New Drug Application (“NDA”) to the Ministry of Health, Labour and Welfare (“MHLW”) in Japan for the approval of fruquintinib for the treatment of adult patients with previously